Thirty-three three Years of Rapid Case Ascertainment: Lessons Learned

Similar documents
Objectives. Cancer Registry Abstracting

The National Program of Cancer Registries (NPCR) Annual Program Evaluation: Ten Years of Partnership and Progress

Collection and Use of Industry and Occupation Data IV: Development of Training Materials to Improve Occupational Data Collection in Cancer Registries

CCSS: HIPAA-Compliant Recruitment. Dennis Deapen, DrPH CCSS Annual Investigators Meeting Memphis, TN October 9-11, 2005

Season s Greetings from all of us to all of you!

Maximizing EHR Data for Public Health Reporting. Nedra Garrett, MS Centers for Disease Control & Prevention February 21, 2017

Not the Same Old EOD: the New and Improved SEER EOD for 2018 and Beyond

Quality of Electronic Pathology (E-path) Records: A Function of Time, X Factors and One Constant

Responsibilities of Public Health Departments to Control Tuberculosis

2/20/2013. Statewide, Population-Based, Incidence. Dr. Youjie Huang DOH State Director of Cancer Registry Operations

AHIMA/NCRA Cancer Registry Management Program PROFESSIONAL PRACTICE EXPERIENCE REQUIREMENT

PEER REVIEW VISIT REPORT (MULTI-DISCIPLINARY TEAM)

HEALTH INFORMATION TECHNOLOGY (HIT) COURSES

Registry of the Future Open Forum: Real-Time Reporting Update and Discussion

Caregivers of Lung and Colorectal Cancer Patients

Case-Mix Data for Case Ascertainment

How to Submit Projects to the Global Oncology Map Website

Environmental Public Health

Northwestern University Department of Urology

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE. Angel L. Moore, MAEd, RHIA Eastern AHEC REC

CANCER REGISTRY REGULATION

Hospital engagement lessons from the five-country WHO/CIDA initiative

Today s Agenda. Morning. Afternoon

Heart. Failure. Health Program

FREQUENTLY ASKED QUESTIONS

NAACCR Volume V Revisions

Defining Roles within the Cancer Registry

Breast Specimen Repository & Registry Specimen Allocation and Registry Use Policy

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Paving the Path toward Improved Specialty Access What it looks like

SPECIAL PROJECT IN NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER

Eligibility. Program Structure and Process for Receiving Incentives

The Institution s Name, Program Title, and Program Summary are listed below. Contact ADHE for a copy of the proposals.

NYS Congenital Malformations Registry Converting to a Web-based System. NYS Congenital Malformations Registry Converting to a Web-based System

RRT Manual A Resource for Standard 5 Panel Discussion on RRT Cooperative Agreement Program States

ALFRED ALINGU, MD INTERNAL MEDICINE

BREAST CANCER IN CALIFORNIA: STAGE AT DIAGNOSIS AND MEDI-CAL STATUS

Community Care Health Plan Continuity of Care Policy

CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER CONSENT TO PARTICIPATE IN A RESEARCH STUDY

Recruiting emerging leaders in oncology Leaders de demain en oncologie

Basic Concepts of Data Analysis for Community Health Assessment Module 5: Data Available to Public Health Professionals

Health Information Exchange: Substance Abuse Patient Records March 3, 2016

PFF Patient Registry Protocol Version 1.0 date 21 Jan 2016

Chapter 5 Policies and Procedures to Receive Payment for Treatment of Colorectal Cancers, Large Polyp Removals & Adverse Events

Sharing health information electronically eliminates the need for faxing, copying and handcarrying your health record from provider to provider.

Targeted technology and data management solutions for observational studies

Health Informatics. Health Informatics professionals treat technology as a tool that helps patients and healthcare professionals.

The Revised Common Rule

June 23, Dear Ms. Moreland:

Healthcare Solutions Nuance Clintegrity Quality Management Solutions. Quality. The Discipline to Win.

How can oncology practices deliver better care? It starts with staying connected.

EHDI TSI Program Narrative

STD Program Management Outbreak Response Module Pre-Course Exercises

Training Public Health Physicians for Global Health: Challenges and Opportunities

SMO - Histopathology

DATA QUALITY AND DATA USES. Agenda. Chicago, Illinois. Northwestern Memorial Hospital

Chapter 11. Expanding Roles and Functions of the Health Information Management and Health Informatics Professional

The Blue, the Green, and the Toxic:

Alpha-1 Foundation Letter of Intent and Full Application Instructions

Consensus Study Report

Standard Operating Procedure for Community Event-Based Surveillance for Ebola Virus Disease in Sierra Leone

Northern Ireland Peer Review of Cancer MDTs. EVIDENCE GUIDE FOR LUNG MDTs

FAST. A Tuberculosis Infection Control Strategy. cough

Program Highlights. A User s RQRS Experience Mildred Nunez Jones, BA, CTR Northside Hospital Cancer Institute

SAMPLE. Release of Information in California: E-book Series, 12 of 12. Published by:

CALIFORNIA STATE UNIVERSITY LOS ANGELES. for PROJECTS FUNDED BY THE PUBLIC HEALTH SERVICE (PHS)

Introduction Remit Eligibility Online application system Project summary Objectives Project details...

TECHNOLOGY IN MEDICINE

National Public Health Performance Standards. Local Assessment Instrument

2017 SP3 (SPORE-Program-Project-Planning) Grant Pilot Award Masonic Cancer Center, University Of Minnesota

Substance Use Disorder Treatment Provider Programmatic Site Visit Monitoring Tool. Date of Review: Review for County Fiscal Year: -

The Specialist in Surgical, Core and Pathology Specimen Radiography

Retrospective Chart Review Studies

INTEGRATING EMS DATA COLLECTION & TRAUMA REGISTRY Joe Moreland. Kansas Board of EMS April 21, 2015

Registry data for disease mapping & spatial epidemiology in Finland

CATERPILLAR GRANTS YEAR 4: PROMOTING ACTIONS AROUND THE BREAST CANCER CONTINUUM OF CARE

NOTICE OF PRIVACY PRACTICES

DRGs & MS-DRGs. System that takes into consideration the role that a hospitals case mix plays in influencing costs

Occupational Health and Safety Situation and Research Priority in Thailand

Third Thursday Volunteer Orientation

TARGETED RFA IN PROSTATE CANCER RESEARCH Predictive Markers

POPULATION HEALTH DIVISION Protecting and Promoting Health & Equity

Medical Records Ch. 13. Dr. Thorson

PATIENT INFORMATION RESPONSIBLE PARTY INFORMATION NAME: DOB: SEX: M / F SOCIAL SECURITY # RELATIONSHIP TO PATIENT: PHONE #: CELL#: EMPLOYER:

Dear Prospective Presenter:

Protocol Feasibility and Operationalization Framework. Beth Harper, BS, MBA. President, Clinical Performance Partners, Inc.

M Health: Tshwane COPC Experience. Jannie Hugo Family Medicine

Kentucky Sepsis Summit. August 2016

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

Domestic Violence Screening in Women s Health: Rooming Alone

WorkSafeBC-CHSPR Research Partnership

7. The NHLS is an equal opportunity, affirmative action employer. The filing of posts will be guided by the NHLS employment Equity Targets.

Policy for Administering the BCCCNP Effective 07/01/2016

Patient Navigation Programs Leveraging Care Pathways. Tina Evans, RN, BS Director of Nursing,Onco-Nav

Role of National TB Program in LTBI Reseach. Dr Hung, Vietnam

Ontario s Digital Health Assets CCO Response. October 2016

Main Study Informed Consent Form, Version D (Direct)

FAQs March 12, 2012 FREQUENTLY ASKED QUESTIONS

CITY OF GRANTS PASS SURVEY

Infectious Diseases-HAI, Infectious Diseases Connecticut Department of Public Health, Infectious Disease: Healthcare Associated Infections, STD/TB

Transcription:

Thirty-three three Years of Rapid Case Ascertainment: Lessons Learned Dennis Deapen, DrPH Los Angeles Cancer Surveillance Program NAACCR Annual Meeting Cambridge, MA June 8, 2005

RAPID CASE ASCERTAINMENT (RCA) Purpose Methods Costs/challenges Potential additional benefits Future directions

RCA ENHANCES RESEARCH Identification of people newly diagnosed with cancer For invitation to participate in epidemiologic and clinical research

RCA ENHANCES RESEARCH Benefits Maximizes participation in population- based research Rapidly fatal or debilitating diseases: lung, ovary, pancreas Highly mobile populations: younger, oldest, immigrants

RCA ENHANCES RESEARCH Benefits Enhance study quality Minimizes recall loss and bias Permits prospective research Treatment decision-making Understanding barriers to treatment Quality of life Some funding streams require RCA

METHODS Two-stage reporting Initial report, typically based on pathology report Site Histology Patient identifiers Patient contact information Physician contact information Subsequent report full abstract

METHODS Two-stage reporting Initial report Days or weeks after diagnosis Subsequent report full abstract Four to six months after diagnosis, or longer

METHODS Los Angeles Cancer Surveillance Program RCA since 1972 Four to twelve simultaneous researcher-initiated RCA-based studies 100% pathology screening at all hospitals by central registry staff Eligibility criteria are screened for all studies simultaneously

METHODS Los Angeles Cancer Surveillance Program All pathology reports for reportable cases are photocopied Pathology reports contain little patient identifier and contact information For RCA study-eligible reports, patient identifiers and contact information are collected from electronic hospital admission record and written on report

METHODS Los Angeles Cancer Surveillance Program Every hospital screened at least monthly Pathology reports hand-delivered delivered to central registry at least weekly Staff enters diagnosis and patient data into RCA database, assigns unique identifier barcode Copies of RCA study-eligible pathology reports hand or overnight delivered to investigator

METHODS Los Angeles Cancer Surveillance Program Timeliness monitoring Review weekly report Overall By study By steps in the process More detailed reports available by Hospital Field abstractor

METHODS Los Angeles Cancer Surveillance Program Typical results (days): Path date to ascertainment by field technician: 20 Ascertainment to delivery to central registry: 4 Delivery to central registry to delivery to investigator: 4 Overall: 28

COSTS About $22 per delivered pathology report Average 1.5 pathology reports per diagnosis Cost covered in investigators research funding

CHALLENGES In Los Angeles, cases not found in hospital pathology files are not included due to: Other hospital databases not screened Lack of patient contact information Free-standing pathology laboratories Late in casefinding process Physician-only Out of catchment area DC only

CHALLENGES Difficult to staff and manage, if not continuous Difficult to understand reasons for ~15% invalid addresses

CHALLENGES Too rapid? Prior to notification of diagnosis to patient? 28 day average from pathologic diagnosis to delivery to investigator Investigator must contact physician and either Receive permission Wait two weeks California policy: Investigator must wait six weeks from pathology date before contacting patient

BENEFITS Los Angeles performs 100% pathology screening Continuous casefinding audit enhances: Completeness of routine reporting Timeliness of routine reporting

BENEFITS Expands public health value of the registry Provides desirable research potential for local investigators Provides revenue streams for registry Provides justification for registry funding

BENEFITS Extremely popular among cancer patients Thousands are contacted annually in Los Angeles Opportunity to fight back or, at least, benefit others Low refusal rate

Epath FUTURE DIRECTIONS Relatively expensive initially Less costly than manual casefinding, especially including travel time Offers very fast and efficient RCA capability Can assist hospital registrars in casefinding Protects confidentiality and enhances HIPAA compliance

SEE OUR POSTER! Donna Morrell can answer questions P-39